 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$2.40 |
$2.49 |
$2.31 |
$2.36 |
316.80K | | 04/22/2024 |
$2.39 |
$2.51 |
$2.35 |
$2.42 |
208.10K | | 04/23/2024 |
$2.45 |
$2.51 |
$2.37 |
$2.38 |
189.50K | | 04/24/2024 |
$2.40 |
$2.47 |
$2.33 |
$2.37 |
322.90K | | 04/25/2024 |
$2.35 |
$2.40 |
$2.27 |
$2.29 |
160.40K |
|
|
| AC Immune is a clinical stage biopharmaceutical company focused on developing medicine for neurodegenerative diseases. Co.'s clinical stage product candidates include: ACI-35.030, which targets pathological Tau and is intended as a disease-modifying treatment for Alzheimer's disease (AD) and other Tauopathies; Semorinemab, which is designed to slow the prion-like propagation of Tau pathology; ACI-24, in which it owns the global rights to ACI-24 and it develops ACI-24 in-house for AD and Down syndrome-related AD; and diagnostic candidates, in which it continues to develop its complementary diagnostic product candidates for Tau, a-syn (with Life Molecular Imaging SA) and TDP-43. | |
|
AC Immune SA (ACIU) has the following price history information. Looking back at ACIU historical stock prices for the last five trading days, on April 19, 2024, ACIU opened at $2.40, traded as high as $2.49 and as low as $2.31, and closed at $2.36. Trading volume was a total of 316.80K shares. On April 22, 2024, ACIU opened at $2.39, traded as high as $2.51 and as low as $2.35, and closed at $2.42. Trading volume was a total of 208.10K shares. On April 23, 2024, ACIU opened at $2.45, traded as high as $2.51 and as low as $2.37, and closed at $2.38. Trading volume was a total of 189.50K shares. On April 24, 2024, ACIU opened at $2.40, traded as high as $2.47 and as low as $2.33, and closed at $2.37. Trading volume was a total of 322.90K shares. On April 25, 2024, ACIU opened at $2.35, traded as high as $2.40 and as low as $2.27, and closed at $2.29. Trading volume was a total of 160.40K shares.
ACIU Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AC Immune SA shares, starting with a $10,000 purchase of ACIU, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/26/2016 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$16.50 |
|
| End price/share: |
$2.29 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-86.12% |
|
| Average Annual Total Return: |
-22.93% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,387.36 |
|
| Years: |
7.58 |
|
|
|
| Date |
Close |
| 04/19/2024 | $2.36 | | 04/22/2024 | $2.42 | | 04/23/2024 | $2.38 | | 04/24/2024 | $2.37 | | 04/25/2024 | $2.29 |
|
|
